BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8995549)

  • 1. Serum inhibin and disease status in women with ovarian granulosa cell tumors.
    Boggess JF; Soules MR; Goff BA; Greer BE; Cain JM; Tamimi HK
    Gynecol Oncol; 1997 Jan; 64(1):64-9. PubMed ID: 8995549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study of inhibin in granulosa cell tumors of the ovary.
    Jobling T; Mamers P; Healy DL; MacLachlan V; Burger HG; Quinn M; Rome R; Day AJ
    Gynecol Oncol; 1994 Nov; 55(2):285-9. PubMed ID: 7959297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulosa cell tumors of the ovary: the clinical value of serum inhibin A and B levels in a large single center cohort.
    Mom CH; Engelen MJ; Willemse PH; Gietema JA; ten Hoor KA; de Vries EG; van der Zee AG
    Gynecol Oncol; 2007 May; 105(2):365-72. PubMed ID: 17306349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibin as a marker for granulosa-cell tumors.
    Lappöhn RE; Burger HG; Bouma J; Bangah M; Krans M; de Bruijn HW
    N Engl J Med; 1989 Sep; 321(12):790-3. PubMed ID: 2770810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retroperitoneal nodal metastasis in primary and recurrent granulosa cell tumors of the ovary.
    Abu-Rustum NR; Restivo A; Ivy J; Soslow R; Sabbatini P; Sonoda Y; Barakat RR; Chi DS
    Gynecol Oncol; 2006 Oct; 103(1):31-4. PubMed ID: 16537089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors.
    Healy DL; Burger HG; Mamers P; Jobling T; Bangah M; Quinn M; Grant P; Day AJ; Rome R; Campbell JJ
    N Engl J Med; 1993 Nov; 329(21):1539-42. PubMed ID: 8413476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy of advanced ovarian juvenile granulosa cell tumors.
    Schneider DT; Calaminus G; Wessalowski R; Pathmanathan R; Harms D; Göbel U
    Klin Padiatr; 2002; 214(4):173-8. PubMed ID: 12165898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of inhibin immunoreactivity in post-menopausal women with ovarian tumours.
    Burger HG; Robertson DM; Cahir N; Mamers P; Healy DL; Jobling T; Groome N
    Clin Endocrinol (Oxf); 1996 Apr; 44(4):413-8. PubMed ID: 8706307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibin and ovarian cancer].
    Burger HG; Baillie A; Drummond AE; Healy DL; Jobling T; Mamers P; Robertson DM; Susil B; Cahir N; Shen Y; Verity K; Fuller PJ; Groome NP; Findlay JK
    Vopr Onkol; 1999; 45(4):369-73. PubMed ID: 10532093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibin-producing ovarian granulosa cell tumor as a cause of secondary amenorrhea: case report and review of the literature.
    Kurihara S; Hirakawa T; Amada S; Ariyoshi K; Nakano H
    J Obstet Gynaecol Res; 2004 Dec; 30(6):439-43. PubMed ID: 15566459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of inhibin and p53 in granulosa cell tumors of the ovary.
    Gebhart JB; Roche PC; Keeney GL; Lesnick TG; Podratz KC
    Gynecol Oncol; 2000 May; 77(2):232-6. PubMed ID: 10785470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone synthesis and responsiveness of spontaneous granulosa cell tumors in (SWR x SWXJ-9) F1 mice.
    Gocze PM; Beamer WG; de Jong FH; Freeman DA
    Gynecol Oncol; 1997 Apr; 65(1):143-8. PubMed ID: 9103404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical utility of serum anti-Müllerian hormone in the follow-up of ovarian adult-type granulosa cell tumors--A comparative study with inhibin B.
    Färkkilä A; Koskela S; Bryk S; Alfthan H; Bützow R; Leminen A; Puistola U; Tapanainen JS; Heikinheimo M; Anttonen M; Unkila-Kallio L
    Int J Cancer; 2015 Oct; 137(7):1661-71. PubMed ID: 25808251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation treatment of advanced or recurrent granulosa cell tumor of the ovary.
    Wolf JK; Mullen J; Eifel PJ; Burke TW; Levenback C; Gershenson DM
    Gynecol Oncol; 1999 Apr; 73(1):35-41. PubMed ID: 10094877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibin as a marker for granulosa cell tumor.
    Lappöhn RE; Burger HG; Bouma J; Bangah M; Krans M
    Acta Obstet Gynecol Scand Suppl; 1992; 155():61-5. PubMed ID: 1502891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of serum alpha-beta A immunoreactive inhibin and tumor-associated antigens CA125 and CEA in ovarian cancer.
    Phocas I; Sarandakou A; Sikiotis K; Rizos D; Kalambokis D; Zourlas PA
    Anticancer Res; 1996; 16(6B):3827-31. PubMed ID: 9042265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of inhibin forms and their measurement by an inhibin alpha-subunit ELISA in serum from postmenopausal women with ovarian cancer.
    Robertson DM; Stephenson T; Pruysers E; McCloud P; Tsigos A; Groome N; Mamers P; Burger HG
    J Clin Endocrinol Metab; 2002 Feb; 87(2):816-24. PubMed ID: 11836327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of inhibin as a tumor marker in granulosa cell tumors. Apropos of 6 new cases treated at the Gustave-Roussy Institute].
    Pautier P; Bidart JM; Lallou N; Duvillard P; Michel G; Droz JP; Lhommé C
    Bull Cancer; 1995 Jul; 82(7):557-60. PubMed ID: 7549118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibin forms in serum from postmenopausal women with ovarian cancers.
    Robertson DM; Cahir N; Burger HG; Mamers P; Groome N
    Clin Endocrinol (Oxf); 1999 Mar; 50(3):381-6. PubMed ID: 10435065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased serum level of inhibin causes amenorrhea in a granulosa cell tumor patient.
    Sakamoto S; Sakamoto M; Nagai A; Obayashi S; Kubota T; Aso T
    Acta Obstet Gynecol Scand; 1998 Feb; 77(2):243-4. PubMed ID: 9512338
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.